产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
---|---|---|---|---|
R763128 | 110764-35-7 | (6R,7R)-7-[[(2S)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 95% (6R,7R)-7-[[(2S)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 95% |
C18H19N3O5S | |
R763351 | 131918-73-5 | (8R,9S,10R,11S,13S,16R,17S)-11,16,17-三羟基-17-(2-羟基乙酰基)-10,13-二甲基-6,7,8,9,10,11, 12,13,16,17-十氢-3H-环戊[a]菲蒽-3-酮, 95% ((8R,9S,10R,11S,13S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one), 95% |
C21H26O6 | |
R685904 | 1516887-33-4 | (E)-3α-羟基-6-亚乙基-7-酮-5β-胆烷-24-酸, 99% (R)-4-((3R,5R,8S,9S,10R,13R,14S,17R,E)-6-Ethylidene-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid, 99% |
C26H40O4 | |
R685903 | 1516887-33-4 | (E)-3α-羟基-6-亚乙基-7-酮-5β-胆烷-24-酸, 99.5% (R)-4-((3R,5R,8S,9S,10R,13R,14S,17R,E)-6-Ethylidene-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid, 99.5% |
C26H40O4 | |
E763125 | 97164-54-0 | (E)-Ceftriaxone Disodium, 95% (E)-Ceftriaxone Disodium, 95% |
C18H16N8Na2O7S3 | |
N763315 | 144391-74-2 | (N-benzyl-4-phenylbutan-1-amine, hydrochloride), 95% (N-benzyl-4-phenylbutan-1-amine, hydrochloride), 95% |
C17H22ClN | |
Q817157 | 100646-51-3 | (R)-2-[4-(6-氯-2-喹啉氧基)-苯氧基]丙酸乙酯, 分析对照品, 96% Ethyl (R)-2-[4-[(6-Chloroquinoxalin-2-yl)oxy]phenoxy]propanoate, 分析对照品, 96% |
C19H17ClN2O4 | |
R763337 | 486460-31-5 | (R)-3-氨基-4-(2,5-二氟苯基)-1-(3-(三氟甲基)-5,6-二氢-[1,2,4]三唑[4,3-a]吡嗪-7(8H-基)丁-1-酮, 95% (R)-3-amino-4-(2,5-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one, 95% |
C16H16F5N5O | |
S747749 | 26001-32-1 | (S)-1-((S)-1-((2S,3S)-2-氨基-3-甲基戊酰基)吡咯烷-2-羰基)吡咯烷-2-甲酸, 98% (S)-1-((S)-1-((2S,3S)-2-Amino-3-methylpentanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxylicacid, 98% |
C16H27N3O4 | |
S767712 | 181289-34-9 | (S)-3-(2-氨基-2-氧代乙基)-5-甲基己酸, 98% (S)-3-(2-Amino-2-oxoethyl)-5-methylhexanoic acid, 98% |
C9H17NO3 | |
S763299 | 304462-60-0 | (S)-3-(3-(((3,4-二甲氧基双环[4.2.0]八-1,3,5-三烯-7-基)甲基)(甲基)氨基)丙基)-7-羟基-8-甲氧基-1,3,1,5-四氢-2H-苯并氮杂-2-酮, 95% (S)-3-(3-(((3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7-hydroxy-8-methoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one (Ivabradine Impurity), 95% |
C26H34N2O5 | |
S763204 | 103129-58-4 | (S)-Ethyl 2-(((S)-1-(2-ethoxy-2-oxoethyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl)amino)-4-phenylbutanoate, 95% (S)-Ethyl 2-(((S)-1-(2-ethoxy-2-oxoethyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl)amino)-4-phenylbutanoate, 95% |
C26H32N2O5 | |
Z763129 | 114876-72-1 | (Z)-cefprozil hydrate, 95% (Z)-cefprozil hydrate, 95% |
C18H21N3O6S(free) | |
H763297 | 906626-51-5 | ([4-(2,6-diamino-9H-purin-9-yl)cyclopent-2-enyl]methanol), 95% ([4-(2,6-diamino-9H-purin-9-yl)cyclopent-2-enyl]methanol), 95% |
C11H14N6O | |
N680006 | 958293-79-3 | (±)-萘普生-D3, 95%(CP), 98 atom % D (±)-Naproxen-D3, 95%(CP), 98 atom % D |
C14D3H11O3 | |
D763358 | 105613-90-9 | 1,2-Dihydro Fluticasone Propionate, 95% 1,2-Dihydro Fluticasone Propionate, 95% |
C25H33F3O5S | |
D763259 | 62749-46-6 | 1,6-Dihydro-6-oxo(3,4'-bipyridine)-5-carboxamide, 95% 1,6-Dihydro-6-oxo(3,4'-bipyridine)-5-carboxamide, 95% |
C11H9N3O2 | |
O763352 | 1219174-94-3 | 11-丙酸氟替卡松, 95% 11-Oxo Fluticasone Propionate, 95% |
C25H29F3O5S | |
H750814 | 850023-80-2 | 17-alpha-羟基孕酮 d8, ≥98 atom % D 17α-Hydroxy Progesterone-d8, ≥98 atom % D |
C21H22D8O3 | |
B680007 | 116360-82-8 | 17-羟基岩大戟内酯B, ≥98%(HPLC) 17-hydroxyjolkinolide B, ≥98%(HPLC) |
C20H28O4 |